Back to mobile site

Dyne Therapeutics (DYN) PT Lowered to $30 at RBC Capital Following NVS Setback

September 9, 2026 7:23 AM EDT Send to a Friend
(Updated - September 9, 2026 7:53 AM EDT)

RBC Capital analyst Luca Issi lowered the price target on Dyne ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login